Clinical Trial

Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery

Study acronym: Vs
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Orthopedic wrist procedures often cause significant postoperative pain. A supraclavicular nerve block is an effective and proven method to help reduce postoperative pain and decrease opioid use around the time of upper extremity surgery. Liposomal bupivacaine (Exparel) has been approved for use around the brachial plexus, but its analgesic efficacy has limited data. The investigators' goal is to evaluate the effectiveness of Exparel as compared to plain bupivacaine. The investigators hope to ensure the quality of pain control around the time of distal radius fracture repair and reduce the variability of care at the investigators institution by prospectively and rigorously collecting perioperative data during this study.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-12-11; most recent amendment 2025-10-23.
Status change: Not Yet Recruiting → Recruiting 2024-06-13
Trial Details
NCT Number NCT06179004
Lead Sponsor University of North Carolina, Chapel Hill
Conditions Distal Radius Fractures, Wrist Fractures
Enrollment 100 participants
Start Date 2024-04-10
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-10-24